Pulmonary Embolism
Symptoms, Doctors, Treatments, Advances & More

Pulmonary Embolism Overview

Save information for later
Sign Up

Learn About Pulmonary Embolism

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Pulmonary Embolism Local Doctors?
Elite in Pulmonary Embolism
Elite in Pulmonary Embolism

Office

70 Francis St, 
Boston, MA 
Languages Spoken:
English

Samuel Goldhaber is a Cardiologist practicing medicine in Boston, Massachusetts. Dr. Goldhaber is rated as an Elite provider by MediFind in the treatment of Pulmonary Embolism. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Pulmonary Embolism, Venous Thromboembolism (VTE), Deep Vein Thrombosis, Embolectomy, and Thrombectomy.

Elite in Pulmonary Embolism
Elite in Pulmonary Embolism

Brigham And Women's Faulkner Hospital, Cardiology Clinic

1153 Centre Street, Suite 4G, 
Jamaica Plain, MA 
Languages Spoken:
English
Offers Telehealth

Dr. Gregory Piazza is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School (HMS).Dr. Piazza received his medical degree from University of Massachusetts Medical School. He completed a residency in internal medicine and fellowships in cardiology and advanced cardiovascular imaging at Beth Israel Deaconess Medical Center. He also served as chief medical resident at Beth Israel Deaconess Medical Center. He then completed a fellowship in vascular medicine at BWH. Dr. Piazza is board certified in internal medicine, cardiovascular disease, vascular medicine and echocardiography.Dr. Piazza’s practice focuses on the evaluation, management and prevention of venous thromboembolism (VTE), thrombosis-related infertility, and stroke prevention in atrial fibrillation. The author of over 140 peer-reviewed publications, his research investigates innovative treatment of VTE, thrombosis-related infertility, and prevention of stroke. Dr. Piazza has received research support from the National Institutes of Health."". Dr. Piazza is rated as an Elite provider by MediFind in the treatment of Pulmonary Embolism. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Pulmonary Embolism, Deep Vein Thrombosis, Venous Thromboembolism (VTE), Embolectomy, and Thrombectomy. Dr. Piazza is board certified in Cardiovascular Disease.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Pulmonary Embolism
Internal Medicine
Elite in Pulmonary Embolism
Internal Medicine

CVI - Cardiovascular Clinic

330 Brookline Avenue, Shapiro 7, 
Boston, MA 
Languages Spoken:
English
Offers Telehealth

Brett Carroll is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Carroll is rated as an Elite provider by MediFind in the treatment of Pulmonary Embolism. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Pulmonary Embolism, Meige Disease, Primary Intestinal Lymphangiectasia, Embolectomy, and Thrombectomy. Dr. Carroll is board certified in American Board Of Internal Medicine.

What are the latest Pulmonary Embolism Clinical Trials?
Ultrasound-assisted, Catheter-directed Thrombolysis for Acute Intermediate-high-risk Pulmonary Embolism (USAT IH-PE): Impact on Short- and Long-term Outcome, a Multi-center Experience. An Observational Retrospective and Prospective Multi-center Study

Summary: The purpose of this retrospective and prospective multicenter study is to evaluate the incidence of pulmonary hypertension (PH) within 6 months from ultrasound-assisted, Catheter-directed Thrombolysis for acute intermediate- high-risk Pulmonary Embolism

Match to trials
Find the right clinical trials for you in under a minute
Get started
ADAPTiON: Apixaban Dose Adjustment in Patient With Thrombocytopenia in ONcology

Summary: This study is being done to determine the feasibility and safety of using a novel dose adjusted apixaban for the management of participants with cancer-associated venous thromboembolism (blood clot) or and thrombocytopenia (low number of platelets in the blood). Investigators are also looking to see if participants on this treatment have fewer bleeding episodes. The name of the study drug involved...